miRNA-194-3p represses NF-κB in gliomas to attenuate iPSC genes and proneural to mesenchymal transition
Authors:
Open Access
- 6 December 2023
- Vol. 27 (1) , 108650
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute (/ NCI 5R01CA188228)
- National Cancer Institute (5UG1CA233331)
This publication has 57 references indexed in Scilit:
- NF-κB-Induced IL-6 Ensures STAT3 Activation and Tumor Aggressiveness in GlioblastomaPLOS ONE, 2013
- Constitutive Activation of Signal Transducer and Activator of Transcription 3 (STAT3) and Nuclear Factor κB Signaling in Glioblastoma Cancer Stem Cells Regulates the Notch PathwayJournal of Biological Chemistry, 2013
- Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamicsProceedings of the National Academy of Sciences of the United States of America, 2013
- Serial selection for invasiveness increases expression of miR-143/miR-145 in glioblastoma cell linesBMC Cancer, 2012
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of GliomaCancer Cell, 2010
- TNF-α/NF-κB/Snail pathway in cancer cell migration and invasionBritish Journal of Cancer, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- A multigene predictor of outcome in glioblastomaNeuro-Oncology, 2009
- Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor GrowthStem Cells, 2009
- NF-κB: a new player in angiostatic therapyAngiogenesis, 2008